Lysophosphatidic acid receptor antagonists and their use in the treatment fibrosis
US9272990B2 · kind B2 · utility
7Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 6, 2011 |
| Grant date | Mar 1, 2016 |
| Priority date | — |
| Expiry date | Aug 20, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/02
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Described herein are compounds that are antagonists of lysophosphatidic receptor(s). Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such antagonists, alone and in combination with other compounds, for treating LPA-dependent or LPA-mediated conditions or diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.